A single duodenal mucosal resurfacing procedure safely elicits favorable disease-modifying metabolic effects in patients with poorly controlled type 2 diabetes, researchers have found.
The international, multiple-site team of investigators reported that the procedure was associated with improvement in several hepatic, glycemic and body-weight parameters over a six-month period.
“Duodenal mucosal resurfacing [DMR] is a novel, minimally invasive, outpatient upper endoscopic ablative procedure